(Q33385079)

26 July 2017

title

Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease (English)

1 reference

26 July 2017

1 reference

Takanori Teshima

1

0 references

author name string

Koji Nagafuji

2

1 reference

26 July 2017

Hideho Henzan

3

1 reference

26 July 2017

Koichi Miyamura

4

1 reference

26 July 2017

Ken Takase

5

1 reference

26 July 2017

Michihiro Hidaka

6

1 reference

26 July 2017

Toshihiro Miyamoto

7

1 reference

26 July 2017

Katsuto Takenaka

8

1 reference

26 July 2017

Koichi Akashi

9

1 reference

26 July 2017

Mine Harada

10

1 reference

26 July 2017

publication date

20 June 2009

1 reference

International Journal of Hematology

26 July 2017

published in

1 reference

26 July 2017

volume

90

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

253-260

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-009-0370-x

26 July 2017

exact match

0 references

cites work

Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS12185-009-0370-X

Rituximab treatment results in impaired secondary humoral immune responsiveness.

21 January 2018

1 reference

12 December 2020

Altered Toll-Like Receptor 9 Responses in Circulating B Cells at the Onset of Extensive Chronic Graft-versus-Host Disease

1 reference

12 December 2020

Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program

1 reference

12 December 2020

Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment

1 reference

12 December 2020

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

1 reference

12 December 2020

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

12 December 2020

Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease

1 reference

12 December 2020

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

1 reference

12 December 2020

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease

1 reference

12 December 2020

Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody

1 reference

12 December 2020

Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations

1 reference

12 December 2020

Murine models of chronic graft-versus-host disease: insights and unresolved issues

1 reference

12 December 2020

Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations

1 reference

12 December 2020

Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

1 reference

12 December 2020

Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment

1 reference

12 December 2020

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. Design of Clinical Trials Working Group report

1 reference

12 December 2020

Low incidence of acute GVHD in patients transplanted with marrow from HLA-A,B,DR-compatible unrelated donors among Japanese

1 reference

12 December 2020

Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.

1 reference

12 December 2020

Performance of a new clinical grading system for chronic graft-versus-host disease: a multicenter study

1 reference

12 December 2020

Rituximab for steroid-refractory chronic graft-versus-host disease

1 reference

12 December 2020

Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors

1 reference

12 December 2020

Chronic graft-versus-host disease: how can we release Prometheus?

1 reference

12 December 2020

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

12 December 2020

Chronic graft-versus-host disease: a prospective cohort study

1 reference

12 December 2020

Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings; possible role of genetic homoge

1 reference

12 December 2020

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

1 reference

12 December 2020

Rituximab as salvage therapy for refractory chronic GVHD

1 reference

12 December 2020

Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation

1 reference

12 December 2020

Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab

1 reference

12 December 2020

Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation

1 reference

12 December 2020

Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire

1 reference

12 December 2020

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

12 December 2020

Chronic graft-versus-host disease

1 reference

12 December 2020

10.1007/S12185-009-0370-X

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

1052880400

0 references

1 reference